Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis

BACKGROUND: Currently, no specific treatment is available for acute onset pancreatitis (AP), and management relies on symptomatic and supportive standard of care (SOC). Fuzapladib is a novel leukocyte function‐associated antigen type‐1 (LFA‐1) activation inhibitor, blocking activation and subsequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Steiner, Joerg M., Lainesse, Chantal, Noshiro, Yuya, Domen, Yumiko, Sedlacek, Heather, Bienhoff, Stephen E., Doucette, Kelly P., Bledsoe, David L., Shikama, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658511/
https://www.ncbi.nlm.nih.gov/pubmed/37811705
http://dx.doi.org/10.1111/jvim.16897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658511/
https://www.ncbi.nlm.nih.gov/pubmed/37811705
http://dx.doi.org/10.1111/jvim.16897

Ejemplares similares